<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McKay GJ</submitter><funding>Economic and Social Research Council</funding><funding>Intramural NIH HHS</funding><funding>British Heart Foundation</funding><funding>NEI NIH HHS</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>1407-16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3217135</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(12)</volume><pubmed_abstract>Age-related macular degeneration (AMD) is the most common cause of incurable visual impairment in high-income countries. Previous studies report inconsistent associations between AMD and apolipoprotein E (APOE), a lipid transport protein involved in low-density cholesterol modulation. Potential interaction between APOE and sex, and smoking status has been reported. We present a pooled analysis (n = 21,160) demonstrating associations between late AMD and APOε4 (odds ratio [OR] = 0.72 per haplotype; confidence interval [CI]: 0.65-0.74; P = 4.41×10(-11) ) and APOε2 (OR = 1.83 for homozygote carriers; CI: 1.04-3.23; P = 0.04), following adjustment for age group and sex within each study and smoking status. No evidence of interaction between APOE and sex or smoking was found. Ever smokers had s</pubmed_abstract><journal>Human mutation</journal><pubmed_title>Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies.</pubmed_title><pmcid>PMC3217135</pmcid><funding_grant_id>MC_PC_U127584475</funding_grant_id><funding_grant_id>G0700704B</funding_grant_id><funding_grant_id>R01 EY016862</funding_grant_id><funding_grant_id>G0000067</funding_grant_id><funding_grant_id>MC_U127584475</funding_grant_id><funding_grant_id>ZIA EY000475</funding_grant_id><funding_grant_id>ES/G007438/1</funding_grant_id><funding_grant_id>NF-SI-0507-10094</funding_grant_id><funding_grant_id>G0601354</funding_grant_id><funding_grant_id>MC_PC_U127561128</funding_grant_id><funding_grant_id>RG/10/12/28456</funding_grant_id><funding_grant_id>R01 EY011309</funding_grant_id><pubmed_authors>Dasari S</pubmed_authors><pubmed_authors>Seland JH</pubmed_authors><pubmed_authors>Abecasis GR</pubmed_authors><pubmed_authors>Soubrane G</pubmed_authors><pubmed_authors>Gorin MB</pubmed_authors><pubmed_authors>Othman M</pubmed_authors><pubmed_authors>Yates JR</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Klaver CC</pubmed_authors><pubmed_authors>Vingerling JR</pubmed_authors><pubmed_authors>Klein ML</pubmed_authors><pubmed_authors>Seddon JM</pubmed_authors><pubmed_authors>Moore AT</pubmed_authors><pubmed_authors>Hayward C</pubmed_authors><pubmed_authors>Ennis S</pubmed_authors><pubmed_authors>Kanda A</pubmed_authors><pubmed_authors>Wright AF</pubmed_authors><pubmed_authors>Fletcher AE</pubmed_authors><pubmed_authors>Fritsche LG</pubmed_authors><pubmed_authors>Weeks DE</pubmed_authors><pubmed_authors>Ho L</pubmed_authors><pubmed_authors>Patterson CC</pubmed_authors><pubmed_authors>Attia J</pubmed_authors><pubmed_authors>Rahu M</pubmed_authors><pubmed_authors>Francis PJ</pubmed_authors><pubmed_authors>Silvestri G</pubmed_authors><pubmed_authors>Weber BH</pubmed_authors><pubmed_authors>Vioque J</pubmed_authors><pubmed_authors>Webster AR</pubmed_authors><pubmed_authors>Tomazzoli L</pubmed_authors><pubmed_authors>Peter I</pubmed_authors><pubmed_authors>Young IS</pubmed_authors><pubmed_authors>Lotery AJ</pubmed_authors><pubmed_authors>Sofat R</pubmed_authors><pubmed_authors>Cipriani V</pubmed_authors><pubmed_authors>Keilhauer CN</pubmed_authors><pubmed_authors>McKay GJ</pubmed_authors><pubmed_authors>Kuo CL</pubmed_authors><pubmed_authors>Guymer RH</pubmed_authors><pubmed_authors>Chakravarthy U</pubmed_authors><pubmed_authors>Topouzis F</pubmed_authors><pubmed_authors>Thakkinstian A</pubmed_authors><pubmed_authors>Baird PN</pubmed_authors><pubmed_authors>Hingorani AD</pubmed_authors><pubmed_authors>de Jong PT</pubmed_authors><pubmed_authors>Swaroop A</pubmed_authors><pubmed_authors>Stambolian D</pubmed_authors><pubmed_authors>Orlin A</pubmed_authors><pubmed_authors>Sawitzke J</pubmed_authors><pubmed_authors>Dean M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies.</name><description>Age-related macular degeneration (AMD) is the most common cause of incurable visual impairment in high-income countries. Previous studies report inconsistent associations between AMD and apolipoprotein E (APOE), a lipid transport protein involved in low-density cholesterol modulation. Potential interaction between APOE and sex, and smoking status has been reported. We present a pooled analysis (n = 21,160) demonstrating associations between late AMD and APOε4 (odds ratio [OR] = 0.72 per haplotype; confidence interval [CI]: 0.65-0.74; P = 4.41×10(-11) ) and APOε2 (OR = 1.83 for homozygote carriers; CI: 1.04-3.23; P = 0.04), following adjustment for age group and sex within each study and smoking status. No evidence of interaction between APOE and sex or smoking was found. Ever smokers had s</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Dec</publication><modification>2026-04-15T11:23:52.109Z</modification><creation>2026-04-07T13:55:36.254Z</creation></dates><accession>S-EPMC3217135</accession><cross_references><pubmed>21882290</pubmed><doi>10.1002/humu.21577</doi></cross_references></HashMap>